Colonic telangiectasias in progressive systemic sclerosis

Bindia Jharap(Meander Medisch Centrum), Stéphanie Van Weyenberg(Vrije Universiteit Amsterdam), Andra Neefjes‐Borst(Amsterdam University Medical Centers), Lyan G. Koudstaal(Amsterdam UMC Location Vrije Universiteit Amsterdam)

Endoscopy

March 6, 2012

10.1055/s-0031-1291521

Cited by 8

Related Papers

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

|Clinical and Translational Gastroenterology|2016|724

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

|Gut|2019|221

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

|Inflammatory Bowel Diseases|2010|199

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

|Gut|2013|144

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

|Nature Clinical Practice Gastroenterology &#38 Hepatology|2007|129